Key terms

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest LXRX news

Mar 25 4:19pm ET Lexicon files to sell 57.66M shares of common stock for holders Mar 25 9:23am ET Lexicon announces presentations of clinical data on sotagliflozin Mar 14 11:01am ET Biotech Alert: Searches spiking for these stocks today Mar 14 7:20am ET Analysts’ Top Healthcare Picks: REPRO-MED Systems (KRMD), Catalyst Pharma (CPRX) Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today Mar 12 8:35am ET Lexicon announces post hoc analysis of data from inTandem3 Phase 3 trial Mar 11 12:01pm ET Analysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX) Mar 11 7:42am ET Lexicon Pharmaceuticals Launches Strategic Private Placement Mar 11 7:27am ET Lexicon announces $250M private equity placement Mar 11 7:17am ET Lexicon reports Q4 EPS (20c), consensus (22c) Mar 11 7:11am ET Lexicon preparing to resubmit sotagliflozin NDA mid-year Feb 21 8:45am ET Largest borrow rate increases among liquid names Feb 16 8:45am ET Largest borrow rate increases among liquid names Feb 14 11:08am ET Biotech Alert: Searches spiking for these stocks today Feb 12 8:45am ET Largest borrow rate increases among liquid names Feb 09 8:45am ET Largest borrow rate increases among liquid names Feb 06 8:45am ET Largest borrow rate increases among liquid names Feb 06 4:55am ET Lexicon management to meet with Piper Sandler Feb 05 8:45am ET Largest borrow rate increases among liquid names Feb 02 8:45am ET Largest borrow rate increases among liquid names Jan 31 7:55am ET Lexicon management to meet with Piper Sandler Jan 30 8:45am ET Largest borrow rate increases among liquid names Jan 26 11:25am ET Biotech Alert: Searches spiking for these stocks today Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today Jan 25 11:38am ET Biotech Alert: Searches spiking for these stocks today Jan 24 9:40am ET Unusually active option classes on open January 24th Jan 17 8:45am ET Largest borrow rate increases among liquid names Jan 12 7:40am ET Analysts Are Bullish on Top Healthcare Stocks: Cooper Co (COO), Lexicon Pharmaceuticals (LXRX) Jan 09 8:45am ET Largest borrow rate increases among liquid names Jan 08 7:19am ET Lexicon provides business, pipeline update at JPMorgan conference Dec 28 11:14am ET Biotech Alert: Searches spiking for these stocks today

No recent press releases are available for LXRX

LXRX Financials

1-year income & revenue

Key terms

LXRX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

LXRX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms